MedTrace Logo

Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel

NCT01448759 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-04-24

No results posted yet for this study

Summary

The purpose of this study is to evaluate plasma alcohol concentration in patients receiving Paclitaxel or Docetaxel infusion.

Conditions

Interventions

OTHER

blood sampling

Other: Blood sampling 10mL of peripherical blood will be collected specially for the study. It's an additional blood sampling compare to the normal follow up of the patient.

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Principal Investigators

  • LE TOURNEAU Christophe, MD · Institut Curie

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01448759 on ClinicalTrials.gov